Biology Reference
In-Depth Information
Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arno A,
Clotet B. 1998. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy
in human immunode®ciency virus-infected patients. J Infect Dis 177: 1080±1083.
Valdez H, Smith KY, Landay A, et al. 2000. Response to immunization with recall and neoantigens
after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375
team. AIDS Clinical Trials Group. AIDS 14: 11±21.
Valentine F. E¨ects of HAART plus an inactivated immunogen on LPR to HIV antigens. 12th
World AIDS Conference. Geneva, Switzerland.
Valentine F, De Gruttola V, and the Remune 316 Study Team. Immunological and virological
evaluations of the e¨ects of HAART compared to HAART plus an inactivated HIV immu-
nogen after 32 weeks [Abstract]. 6th Conference on Retrovirus and Opportunistic Infections,
Chicago, IL.
Wei X, Ghosh SK, Taylor ME, et al. 1995. Viral dynamics in human immunode®ciency virus type 1
infection. Nature 373: 117±122.
Weichold FF, Bryant JL, Pati S, Barabitskaya O, Gallo RC, Reitz Jr MS. 1999. HIV-1 protease
inhibitor ritonavir modulates susceptibility to apoptosis of uninfected T cells [In Process Cita-
tion]. J Hum Virol 2: 261±269.
Wendland T, Furrer H, Vernazza PL, Frutig K, Christen A, Matter L, Malinverni R, Pichler WJ.
1999. HAART in HIV-infected patients: restoration of antigen-speci®c CD4 T-cell responses in
vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed
type hypersensitivity is related to a decrease in viraemia. AIDS 13: 1857±1862.
Weverling GJ, Mocroft A, Ledergerber B, Kirk O, Gonzales-Lahoz J, d'Arminio Monforte A,
Proenca R, Phillips AN, Lundgren JD, Reiss P. 1999. Discontinuation of Pneumocystis carinii
pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection.
EuroSIDA Study Group. Lancet 353: 1293±1298.
Wolthers KC, Bea G, Wisman A, Otto SA, de Roda Husman AM, Scaft N, de Wolf F, Goudsmit
J, Counho RA, van der Zee AG, Meyaard L, Miedema F. 1996. T cell telomere length in HIV-1
infection: no evidence for increased CD4
T cell turnover. Science 274: 1543±1547.
Wong JK, Gunthard HF, Havler DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E,
Richman DD. 1997. Reduction in HIV-1 in blood and lymph nodes following potent antiviral
therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci USA 94: 12574±
12579.
Zanussi S, Simonelli C, Bortolin MT, D'Andrea M, Crepaldi C, Vaccher E, Nasti G, Politi D.
Barzan L, Tirelli U, De Paoli P. 1999. Immunological changes in peripheral blood and
in lymphoid tissue after treatment of HIV-infected subjects with highly active antiretroviral
therapy (HAART) or HAARTIL2. Clin Exp Immunol 116: 486±492.
Zhang L, Lewin SR, Markowitz M, Lin HH, Skulsky E, Karanicolas R, He Y, Jin X, Tuttleton S,
Vesanen M, Spiegel H, Kost R, van Lunzen J, Stellbrink HJ, Wolinsky S, Borkowsky W,
Palumbo P, Kostrikis LG, Ho DD. 1999a. Measuring recent thymic emigrants in blood of
normal and HIV-1-infected individuals before and after e¨ective therapy. J Exp Med 190: 725±
732.
Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, Talal A, Racz P, Perelson
AS, Korber BT, Markowitz M, Ho DD. 1999b. Quantifying residual HIV-1 replication in
patients receiveing combination antiretroviral therapy. N Engl Med 340: 1605±1613.
